| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_283ac72c1f55764526ded515c131e64e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00a421ab71bd49a451d0a49d23a082c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32aa0b221dcdf46b22eb5b01c12698c9 |
| publicationDate |
2011-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011098509-A1 |
| titleOfInvention |
Phospholipid profiling and cancer |
| abstract |
In general, the present invention provides prognostic and predictive methods and kits for determining the lipogenicity of a tumor in a subject, by making use of phospholipid profiling, whereby a relative increase in mono-unsaturated phospholipid species in combination with a relative decrease in poly-unsaturated phospholipid species is indicative for a more resistant and aggressive lipogenic cancer phenotype. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104285150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9903878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9400274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9817003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018170316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11262359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015192597-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11573177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020182995-A1 |
| priorityDate |
2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |